Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system

Journal of Pharmaceutical Sciences

Volumn 100, Issue 3, 2011, Pages 1067-1079

  Wang, Tiewei ^a   Zhang, Chunling ^b   Liang, Xing Jie ^a   Liang, Wei ^b   Wu, Yan ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

1; 2 dipalmitoyl sn glycero 3 phosphoethanolamine; amphiphilic copolymer; Antitumor activity; Delivery system; Doxorubicin; HP CD; Polylactide

Indexed keywords

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; 3 (4,5 DIMETHYLTHIAZOL 2 YL) 2,5 DIPHENYL TETRAZOLIUM BROMIDE; BROMIDE; COPOLYMER; DOXORUBICIN; POLYLACTIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN HEPG2; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; THERMOGRAVIMETRY;

EID: 79251549800     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22352     Document Type: Article

References (37)

1. Jones M, Leroux J. 1999. Polymeric micelles-a new generation of colloidal drug carriers. Eur J Pharm Biopharm 48:101-111.
2. Torchilin VP. 2001. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73:137-172.
3. Savic R, Luo LB, Eisenberg A, Maysinger D. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300:615-618.
4. Kwon GS, Okano T. 1996. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 21:107-116.
5. Shuai X, Merdan T, Schaper AK, Xi F, Kissel T. 2004. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug Chem 15:441-448.
6. Torchilin V. 2004. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 61:2549-2559.
7. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. 1994. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54:3352-3356.
8. Gabizon AA. 2001. Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest 19:424-436.
9. Trubetskoy VS, Torchilin VP. 1995. Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents. Adv Drug Deliv Rev 16:311-320.
10. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. 2002. Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res 19:1424-1429.
11. Gao Z, Lukyanov AN, Singhal A, Torchilin VP. 2002. Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Lett 2:979-982.
12. Gabizon AA. 1995. Liposome circulation time and tumor targeting: Implications for cancer chemotherapy. Adv Drug Deliv Rev 16:285-294.
13. Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP. 2004. Tumor-targeted liposomes: Doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Control Release 100:135-144.
14. Khan AR, Forgo P, Stine KJ, D'Souza VT. 1998. Methods for selective modifications of cyclodextrins. Chem Rev 98:1977-1996.
15. Uekama K, Hirayama F, Irie T. 1998. Cyclodextrin drug carrier systems. Chem.Rev 98:2045-2076.
16. Kang F, Singh J. 2003. Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis. Int J Pharm 260:149-156.
17. Ionita G, Ionita P, Sahini VE, Luca C. 2001. Influence of cyclodextrins on the kinetics of oxidation of amino acids and BSA by hydrazyl radicals. J Incl Phenom Macrocycl Chem 39:269-271.
18. Chiellini E, Solaro R. 2002. Contents of Macromolecular Symposia 1977th World Conference on biodegradable polymers and plastics, Tirrenia, Pisa (Italy). pp 345-354.
19. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70:1-20.
20. Peczuh MW, Hamilton AD. 2000. Peptide and protein recognition by designed molecules. Chem Rev 100:2479-2494.
21. Welbanks L. 2000. Adriamycin monograph. In: Compendium of pharmaceuticals and specialties Canadian Pharmacists Association, Ottawa, Canada. pp 31-32.
22. Chen Y, Burton MA, Codde JP, Napoli S, Martins IJ, Gray BN. 1992. Evaluation of ion-exchange microspheres as carrier for the anticancer drug doxorubicin: In vitro studies. J Pharm Pharmacol 44:211-215.
23. Lu JY, Lowe DA, Kennedy MD, Low PS. 1999. Folate targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. J Drug Target 7:43-53.
24. Hyon SH, Jamshidi K, Ikada Y. 1997. Synthesis of polylactides with different molecular weights. Biomaterials 18:1503-1508.
25. Xie DM, Yang KS, Sun WX. 2007. Formation and characterization of polylactide and β-cyclodextrin inclusion complex. Curr Appl Phys 7S1:e15-e18.
26. Li J, Chen B, Wang X, Goh SH. 2004. Preparation and characterization of inclusion complexes formed by biodegradable poly(ε-caprolactone)-poly(tetrahydrofuran)-poly(ε-caprolactone) triblock copolymer and cyclodextrins. Polymer 45:1777-1785.
27. Onozuka S, Kojima M, Hattori K, Toda F. 1980. The regiospecific mono tosylation of cyclodextrins. Bull Chem Soc Jpn 53:3221-3224.
28. Nozaki T, Maeda Y, Ito K, Kitano H. 1995. Cyclodextrins modified with polymer chains which are responsive to external stimuli. Macromolecules 28:522-524.
29. Vandoorne F, Vercauteren R, Permentier D, Schacht E. 1985. Re-investigation of 4-nitrophenyl chloroformate activation of dextran. Evidence for the formation of different types of carbonate moieties. Makromol Chem 186:2455-2460.
30. Vandoorne F, Bruneel D, Schacht E. 1990. Effect of chemical modification of dextran on the degradation by dextranase. Bioact Compat Polym 5:4-15.
31. Axén R, Ernback S. 1971. Chemical fixation of enzymes to cyanogen halide activated polysaccharide carriers. Eur J Biochem 18:351-360.
32. Laakso T, Stjärnkvist P Sjöholm. 1987. Biodegradable microspheres. VI: Lysosomal release of covalently bound antiparasitic drugs from starch microparticles. J Pharm Sci 76:134-140.
33. Torchilin VP, Levchenko TS, Lukyanov AN, Khaw BA, Klibanov AL, Rammohan R, Samokhin GP, Whiteman KR. 2001. p-Nitrophenylcarbonyl-PEG-PE-liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim Biophys Acta 1511:397-411.
34. Rodrigues JS, Santos-Magalhaes NS, Coelho LCBB, Couvreur P, Ponchel G, Gref R. 2003. Novel core (polyester)-shell(polysaccharide) nanoparticles: Protein loading and surface modification with lectins. J Control Release 92:103-112.
35. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. 1999. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release 57:171-185.
36. Sabesan S, Neria S. 1992. Synthesis of glycosylphosphates and azides. Carbohyd Res 223:169-185.
37. Lebouc F, Dez I, Madec PJ. 2005. NMR study of the phosphonomethylation reaction on chitosan. Polymer 46:319-325.